2005
HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor
Hui P, Li N, Johnson C, De Wever I, Sciot R, Manfioletti G, Tallini G. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Modern Pathology 2005, 18: 1519-1526. PMID: 16056249, DOI: 10.1038/modpathol.3800464.Peer-Reviewed Original ResearchConceptsMalignant peripheral nerve sheath tumorPeripheral nerve sheath tumorsNerve sheath tumorsSheath tumorsSynovial sarcomaSYT-SSX fusion transcriptsRoutine surgical pathology practiceStaining patternMonophasic synovial sarcomaReal-time reverse transcription-polymerase chain reactionAvailable immunohistochemical markersReverse transcription-polymerase chain reactionSurgical pathology practiceTranscription-polymerase chain reactionExpression of HMGA2Nuclear staining patternHistological diagnosisPolymerase chain reactionProtein immunohistochemistryBiphasic tumorSignificant immunoreactivityImmunohistochemical markersImmunohistochemical stainingSarcomaGlandular component
2004
Differential Expression of HMGA1 and HMGA2 in Dermatofibroma and Dermatofibrosarcoma Protuberans: Potential Diagnostic Applications, and Comparison with Histologic Findings, CD34, and Factor XIIIa Immunoreactivity
Li N, McNiff J, Hui P, Manfioletti G, Tallini G. Differential Expression of HMGA1 and HMGA2 in Dermatofibroma and Dermatofibrosarcoma Protuberans: Potential Diagnostic Applications, and Comparison with Histologic Findings, CD34, and Factor XIIIa Immunoreactivity. American Journal Of Dermatopathology 2004, 26: 267-272. PMID: 15249855, DOI: 10.1097/00000372-200408000-00001.Peer-Reviewed Original Research